Partner Organizations’ Projects

PCM4EU

The project is divided into six work packages, mapping cancer molecular diagnostics in different countries, supporting the creation of new Drug Rediscovery Protocol (DRUP) clinical trials, developing guidelines on how to put together a molecular oncology consortium based on the experience of participating countries, and how to bring drugs and clinical trials to the patient’s home and make it easier for the patient to go to another European country for treatment if they wish.

PRIME-ROSE

The vision of the PRIME-ROSE project is to provide access to affordable personalised precision cancer care that will enable cancer patients to live as long as possible and with the highest possible quality of life. The PRIME-ROSE consortium will use existing adaptive and pragmatic clinical trial platforms to answer key questions about clinical effectiveness, provide health-economic evaluations and contribute to the advancement of science for different cancers. In particular, PRIME-ROSE will enhance the capacity for transnational collaboration and enable cross-trial data pooling and analysis, initiate cross-border collaborative cohorts and provide health economic evaluations. To ensure successful implementation, the consortium will work with regulators, policy makers, funders, healthcare providers and patient support groups to implement evidence-based PCM in practice and address inequalities in access. PRIME-ROSE will therefore address key scientific and methodological issues to accelerate the widespread and widespread use of evidence-based care in the EU.